Women’s Group for the Women’s Health Initiative Investigators. 2002. Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative Randomized Controlled Trail. JAMA 288(3):321-333.
Wysowski DK, Swartz L. 2005. Adverse drug event surveillance and drug withdrawals in the United States, 1969–2002: the importance of reporting suspected reactions. Arch Intern Med 165(12):1363-1369.
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
4 The Science of Safety ."
The Future of Drug Safety: Promoting and Protecting the Health of the Public . Washington, DC: The National Academies Press,
Please select a format: